日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Policies

MNCs feeling buoyant about China in 2022

China Daily | Updated: 2022-01-12 09:59
Share
Share - WeChat

Zhou Xiaolan, president of Bayer Group China

A1 When it comes to 2022 and beyond, we foresee continued growth stability and resilience in China's economy under key priorities of the 14th Five-Year Plan (2021-25) which underscores a commitment to the "dual circulation" concept for economic development, driven by reform and innovation to promote stability and "high-quality development" in China.

A2 Despite challenges and uncertainties last year, our business saw a strong rebound from 2020 and reported encouraging results. As the largest market for Bayer Pharmaceuticals and the second largest for Bayer Consumer Health, China has become one of the most important pillars of Bayer's global business. We expect to carry this promising momentum into this year and beyond.

A3 Bayer supports China's determination to promote economic globalization and opening-up. Thanks to China's efforts to accelerate innovation and improve the business environment in recent years, Bayer has been able to bring in the latest innovative products and solutions to China faster. This includes Bayer Continuous Glucose Monitoring System (CGMs)-an all-new model for intelligent diabetes disease management which was introduced at the Boao Lecheng International Medical Tourism Pilot Zone in 2021.

A4 Contributing to sustainable development has always been a core element of Bayer's corporate strategy and of our core values. We promote inclusive growth and a responsible use of resources to help people and the planet thrive. Bayer is committed to stepping up our efforts in sustainability and helping to resolve major challenges of our times. Bayer launched in September our first Asia-Pacific Forward Farm in China, which plays an innovative and leading role in our sustainability efforts.

A5 The answer is an obvious YES. Our business in China is key to our current and future success. As the business environment continues to improve in China in terms of strengthened IP protections and the roll-out of encouraging laws and regulations, e.g. to accelerate the review and approval of new drugs, we will continue to increase our investment here as we lead and redefine innovation in life sciences.

For example, despite the challenges brought by the pandemic last year, Bayer kicked off the capacity expansion project of our Pharmaceuticals Product Supply Beijing Site. With an investment of more than 50 million euros ($56.49 million), the planned project is designed to increase the production capacity and accelerate the implementation of innovative digital solutions, in order to ensure a reliable supply of high-quality prescription drugs for more Chinese patients.

|<< Previous 1 2 3 4 5 6 7   
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 久久精品无码一区二区日韩av | 免费伊人网 | 国产欧美精品午夜在线播放 | 九草在线 | www.色综合| 一区二区三区四区在线 | 精品一区二区三区在线观看视频 | 亚洲午夜精品aaa级久久久久 | 亚洲伊人成色综合网 | 欧美乱妇在线观看 | 国产欧美成人 | 精品三级国产精品经典三 | 91看片淫黄大片一级在线观看 | 久久婷婷在线 | 国产99久久精品 | 日韩成人在线视频 | 色网在线| 亚洲欧美在线播放 | 日韩小视频 | 日韩黄色在线视频 | 懂色一区二区三区免费观看 | 五月天婷婷精品视频 | 中文成人在线 | 青娱乐精品视频在线观看 | 奇米第四色888 | 免费观看黄色a一级视频播放 | 亚洲视频1 | 免费精品美女久久久久久久久久 | 国产精品免费在线播放 | 亚洲欧美在线观看一区二区 | 免费视频片在线观看大片 | 日韩免费视频 | 欧洲男女下面进出的视频 | 国产精品视频网站 | 极品美女一区二区三区视频 | 中文在线а√在线8 | 国产成人一区二区精品非洲 | 91欧美激情一区二区三区成人 | 99久久这里只有精品 | 一区二区三区在线观看视频 | 国产成人精品免费视频大全最热 |